Kiniksa Pharmaceuticals International KNSA
NASDAQ KNSA
$74.62 -1.11 (-1.47%)
As of: Sep 30, 2026 · 3:59 PM EDT

Kiniksa Pharmaceuticals International (KNSA) Receivables - Other (2022)

Updated

Kiniksa Pharmaceuticals International (KNSA) recorded Receivables - Other of $7.66 million in Q4 2022.

Analysis

Kiniksa Pharmaceuticals International (KNSA) Receivables - Other (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Kiniksa Pharmaceuticals International 11.81 Bn 10.55 Bn 220.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 7.66 Mn
API Access

Kiniksa Pharmaceuticals International Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=KNSA&period=max&api_key=YOUR_API_KEY